Article
Evaluating the evidence for GM-CSF as a host-directed therapy in respiratory infections
24 Feb 2025
Abstract excerpt
Novel therapeutic approaches are needed to treat respiratory infections due to the rising antimicrobial resistance and the lack of effective antiviral therapies. A promising avenue to overcome treatment failure is to develop strategies that target the host immune response rather than the pathogen itself. Granulocyte-macrophage colony-stimulating factor (GM-CSF) plays a critical role in controlling homeostasis in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
